Browsing by Author Zarei, Mohammad
Showing results 1 to 8 of 8
Issue Date | Title | Author(s) |
---|---|---|
1-Nov-2023 | Elafibranor upregulates the EMT-inducer S100A4 via PPARbeta/delta | Zhang, Meijian; Barroso Fernández, Emma; Ruart, Maria; Peña, Lucía; Peyman, Mona; Aguilar-Recarte, David; Montori Grau, Marta; Rada, Patricia; Cugat, Clara; Montironi, Carla; Zarei, Mohammad; Jurado Aguilar, Javier; Camins, Àngels; Balsinde, Jesús; Valverde, Ángela M.; Wahli, Walter; Palomer Tarridas, Francesc Xavier; Vázquez Carrera, Manuel |
2-Nov-2023 | Electrochemical properties of CNT doped nanoporous tin oxide hybrid electrode formed on cold spray tin coating for supercapacitor application | Zarei, Mohammad; Nourouzi, Salman; Jamaati, Roohollah; García Cano, Irene; Sarret i Pons, Maria; Dosta Parras, Sergi; Esmaeili-Faraj, S.H. |
15-Apr-2022 | Endoplasmic reticulum stress downregulates PGC-1α in skeletal muscle through ATF4 and an mTOR-mediated reduction of CRTC2 | Montori Grau, Marta; Aguilar, David; Zarei, Mohammad; Pizarro Delgado, Javier; Palomer Tarridas, Francesc Xavier; Vázquez Carrera, Manuel |
2018 | Hepatic regulation of VLDL receptor by PPARbeta/delta and FGF21 modulates non-alcoholic fatty liver disease | Zarei, Mohammad; Barroso Fernández, Emma; Palomer Tarridas, Francesc Xavier; Dai, Jianli; Rada, Patricia; Quesada López, Tania Paloma; Escolà Gil, Joan Carles; Cedó Giné, Lídia; Zali, Mohammad Reza; Molaei, Mahsa; Dabiri, Reza; Vázquez Cruz, Santiago; Pujol Bech, Eugènia; Valverde, Ángela M.; Villarroya i Gombau, Francesc; Liu, Yong; Wahli, Walter; Vázquez Carrera, Manuel |
30-Mar-2019 | Oral administration of a new HRI activator as a new strategy to improve high-fat-died-induced glucose intolerance, hepatic steatosis and hypertriglyceridemia through FGF21 | Zarei, Mohammad; Pujol Bech, Eugènia; Quesada López, Tania Paloma; Villarroya i Gombau, Francesc; Barroso Fernández, Emma; Vázquez Cruz, Santiago; Pizarro Delgado, Javier; Palomer Tarridas, Francesc Xavier; Vázquez Carrera, Manuel |
20-Mar-2018 | PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders | Palomer Tarridas, Francesc Xavier; Barroso Fernández, Emma; Pizarro Delgado, Javier; Peña, Lucía; Botteri, Gaia; Zarei, Mohammad; Aguilar, David; Montori Grau, Marta; Vázquez Carrera, Manuel |
10-Sep-2020 | SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2 | Barroso Fernández, Emma; Rodríguez-Rodríguez, Rosalia; Zarei, Mohammad; Pizarro Delgado, Javier; Planavila Porta, Ana; Palomer Tarridas, Francesc Xavier; Villarroya i Gombau, Francesc; Vázquez Carrera, Manuel |
26-Jan-2020 | Targeting FGF21 for the treatment of nonalcoholic steatohepatitis | Zarei, Mohammad; Pizarro Delgado, Javier; Barroso Fernández, Emma; Palomer Tarridas, Francesc Xavier; Vázquez Carrera, Manuel |